The increasing comorbid disease burden among patients undergoing coronary artery bypass graft surgery (CABG) and the improved operative survival are expanding the number of post-CABG patients living with prognostically significant comorbidities. In a large contemporary database, 29.9% of the patients receiving isolated CABG had diabetes mellitus, 16% peripheral vascular disease, 18.6% chronic obstructive pulmonary disease, and 27.5% renal dysfunction. Patients with comorbidity are more likely to be old and often female, may have special care-requirements early after discharge, and are at increased risk for adverse outcomes. Contemporary available evidence indicates that older individuals, women, and patients with comorbidities are significantly less likely to receive cardiac rehabilitation. In addition, compliance with proven atherosclerosis risk reduction strategies for CABG patients is suboptimal. In this article we will review the impact of comorbidity on short-term and long-term outcome after CABG and their implications for cardiac rehabilitation.
AbramovDTamarizMGFremesSEGuruVBorgerMAChristakisGTTrends in coronary artery bypass surgery results: a recent, 9 year study. Ann Thorac Surg2000; 70:84–90.
2.
CooperWAO'BrienSMThouraniVHGuytobRABridgesCRSzczechAImpact of renal dysfunction on outcomes of coronary artery bypass surgery. Results from the Society of Thoracic Surgeons National Adult Cardiac database. Circulation2006; 113:1063–1070.
3.
LewyASCoreshJBalkEKauszATLevinASteffesMWNational Kidney Foundation Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Ann Int Med2003; 139:137–147.
4.
CramPRosenthalGEVaughan-SarrazinMS. Cardiac revascularization in specialty and general hospitals. N Engl J Med2005; 352:1454.
5.
RoquesFNashefSAMMichelPGaudicheauEde VincetiisCBaudetERisk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg1999; 15:816–823.
6.
ToumpoulisIKAnagnostopoulosCEDeRoseJJSwistelDG. European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting. Eur J Cardiothorac Surg2004; 25:51–58.
7.
HwangCWAndersonGFDiener-WestMPoweNR. Comorbidity and outcomes of coronary artery bypass graft surgery at cardiac specialty hospitals versus general hospitals. Med Care2007; 45:720–728.
8.
BirkmeyerJDO'ConnorGTQuintonHBRicciMAMortonJRLeavittBJThe effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery. J Vasc Surg1995; 21:445–452.
9.
HannanELWuCBennettEVCarlsonRECullifordATGoldJPRisk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coil Cardiol2006; 47:661–668.
10.
GotoTBabaTYoshitakeAShibataYUraMSakataR. Craniocervical and aortic atheroslerosis as neurologic risk factors in coronary surgery. Ann Thorac Surg2000; 69:834–840.
11.
LeavittBJSheppardLMaloneyCCloughRABraxtonJHCharlesworthDCEffect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgeryCirculation2004; 110 (Suppl II):II-41–II-44.
12.
FilsoufiFRahmanianPBCastilloJGChikweJKiniASAdamsDH. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg2007; 84:808–816.
13.
FusterRGArgudoJAMAlbarovaOGSosFHLopezSCCodonerMBPrognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting. Eur J Cardiothorac Surg2006; 29:202–209.
14.
LeavittBJRossCSSpenceBSurgenorSDOlmsteadEMCloughRALong-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgeryCirculation2006; 114 (Suppl 1):I-430–I-434.
15.
LiuJYBirkmeyerJOMortonJRHenriquezHFLaheySJDowRWRisks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation2000; 102:2973.
16.
SwaminathanMShawADPlilips-ButeBGMcGugan-ClarkPLArcherLETalbertSTrends in acute renal failure associated with coronary artery bypass surgery in the United States. Crit Care Med2007; 35:2286–2291.
17.
BrownJRCochranRPLeavittBJDaceyLJRossCSMacKenzieTAMultivariate prediction of renal insufficiency developing after cardiac surgeryCirculation2007; 116 (Suppl I):I-139–I-143.
18.
BrownJRCochranRPDaceyURossCSKunzelmanKSDuntonRFPerioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgeryCirculation2006; 114 (Suppl I):I-409–I-413.
19.
LokCEAustinPCWangHTuJV. Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery. Am Heart J2004; 148:430–438.
20.
ZakeriRFreemantleNBarnettVLipkinGWBonserRSGrahamRRelation between mild renal dysfunction and outcomes after coronary artery bypass graftingCirculation2005; 112 (Suppl I):I-270–I-275.
21.
SzczechLABestPJCrowleyEBrooksMMBergerPBBittnerVOutcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation2002; 105: 2253–2258.
22.
HillisGSZehrKJWilliamsAWSchaffHVOrzulakTADalyRCOutcome of patients with low ejection fraction undergoing coronary artery bypass grafting. Renal function and mortality after 3.8 yearsCirculation2006; 114 (Suppl I):I-414–I-419.
23.
SolteroERPetersenNJEraleNRGlaeserDHUrbauerDLDeswalA. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease. J Card Fail2005; 11:206–211.
24.
SarnakMJLeveyASSchoolwerthACCoreshJCulletonBHammLLKidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation2003; 108:2154–2169.
25.
McCulloughPA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med2002; 3:71–76.
26.
FurnaryAPGaoGGrunkemeierGLWuYZerrKJBookinSOContinuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg2003; 125:1007–1021.
27.
CarsonJLSchoolzPMChenAYPetersonEDGoldJSchneiderSH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery coronary artery bypass surgery. J Am Coll Cardiol2002; 40:418–423.
28.
FilsoufiFRahamanianPBCastilloJGMechanickJISharmaSKAdamsDH. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg2007; 6:753–758.
29.
RajakarunaCRogersCASuranimalaCAngeliniGDAscioneR. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg2006; 132:802–810.
30.
MohammadiSDagenaisFMathieuPKingmaJGDoyleDLopezSLong-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass surgeryCirculation2007; 116 (Suppl I):I-220–I-225.
31.
HannanELRaczMJWalfordGRyanTJIsomOWBennettEPredictors of readmissions for complications of coronary artery bypass graft surgery. J Am Med Assoc2003; 290:773–780.
32.
SteuerJBlomqvistPGranathFRydhBEkbomAde FaireUHospital readmission after coronary artery bypass grafting: are women doing worse?Ann Thorac Surg2002; 73:1380–1386.
33.
SuayaJAShepardDSNormandS-LTAdesPAProttasJStasonWB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation2007; 116:1653–1662.
34.
CorràUMendesMPiepoliMSanerH. Future perspectives in cardiac rehabilitation: a new European Association for Cardiovascular Prevention and Rehabilitation Position Paper on 'secondary prevention through cardiac rehabilitation'. Eur J Cardiovasc Prev Rehabil2007; 14:723–725.
35.
BaladyGJWilliamsMAAdesPABittnerVComossPFoodyJACore components of cardiac rehabilitation/secondary prevention programs: 2007 Update. A Scientific Statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Council on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, physical activity, and metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Core components of cardiac rehabilitation/Secondary prevention programs: 2007 update. Circulation2007; 115:2675–2682.
36.
HiratzkaLEagleKAFonarowGCLaBreshKAPetersonED. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With The Guidelines databaseCirculation2007; 116 (Suppl I):I-207–I-212.
37.
SmithSCAllenJBlairSNBonowROBrassLMFonarowGCAHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation2006; 113:2363–2372.
38.
WoodD. Clinical reality of coronary prevention in Europe: a comparison of EUROASPIRE I, II and III surveys. ESC Congress 2007. Personal communication.
39.
BonowROMitchWENestoRWO'GaraPTBeckerRCClarkLTPrevention Conference VI. Diabetes and cardiovascular disease. Writing Group V: management of cardiovascular-renal complications. Circulation2002; 105:e159–e164.
40.
Heart Outcome Prevention Evaluation (HOPE) Study Investigators.Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet2000; 355:253–259.
41.
American Diabetes Association.Standards of medical care in diabetes –2007. Diabetes care2007; 30:S4–S41.
42.
American Diabetes Association.Diabetic nephropathy. Diabetes Care2003; 26:S94–S98.
43.
FaggerudJForsblomCPetterson-FernholmKGroopPH. Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care2004; 27:803–804.
44.
GiannuzziPSanerHBjörnstadHFiorettiPMendesMCohen-SolalASecondary prevention through cardiac rehabilitation. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J2003; 24:1273–1278.
45.
National Kidney Foundation (NKF), K/DOQI Work Group.K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis2005; 45 (Suppl 3):S1–S153.
46.
KutnerNGZhangRHuangYHerzogCA. Cardiac rehabilitation and survival on dialysis patients after coronary bypass. J Am Soc Nephrol2006; 17:1175–1180.
47.
IhleBU. Acute renal dysfunction after cardiac surgery: still a big problem!Heart Lung Circulation2007; 16:S39–S44.
48.
TokmakovaMPSkaliHKenchaiahSKBraunwaldERouleauJLChertowGMChronic kideny disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction. The Survival And Ventricular enlargement (SAVE) study. Circulation2004; 110:3667–3673.
49.
SolomonSDRiceMMJablonskiKAPowellJDomanskiMSabatineMRenal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary disease in the prevention of events with ACE inhibiton (PEACE) trial. Circulation2006; 114:26–31.
50.
BrugtsJJBoersmaEChoncholMDeckersJWBertrandMRemmeWJThe cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency. J Am Coll Cardiol2007; 50:2148–2155.
51.
AnavekarNSMcMurrayJJVVelazquezEJSolomonSDKoberLRouleauJ-LRelation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med2004; 351:1285–1295.
52.
CocaSGKrumholzHMGargAXParikhCR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. J Am Med Assoc2006; 296:1377–1384.
53.
FerrariP. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology2007; 12:81–89.
54.
HouFFZhangXZhangGHXieDChenPYZhangWREfficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med2006; 345:131–140.
55.
JosePTomsonCSkaliHRouleauJBraunwaldEArnoldJMInfluence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. J Am Coll Cardiol2006; 47:1725–1727.
56.
SolomonSDLinJSolomonCGJablonskiKAMurguiaMSteffesMInfluence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation2007; 116:2687–2693.
57.
BoydCMDarerJBoultCFriedLPBoultLWuAW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. J Am Med Assoc2005; 294:716–724.
